Ropivacaine Though Laterosternal Catheters After Cardiac Surgery

• Status: Completed
• Trial end date: 2010-11-01
• Target enrollment: 0
• Participant gender: All

Summary

This is a prospective double-blinded and randomised study involving patients undergoing cardiac surgery with median sternotomy, the effects on postoperative analgesia of a 48-hr continuous infusion of ropivacaine 2 mg.mL-1, at the rate of 4 mL.hr-1 through two catheters inserted at the lateral edges of the sternum will be studied, versus a control group in which normal saline will be infused in the same conditions.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University Hospital, Clermont-Ferrand
• Treatments: Ropivacaine

Criteria

Inclusion Criteria:

• Scheduled cardiac surgery.

Exclusion Criteria:

• - surgery in emergency

• thoracotomy

• cardiac graft

• redo

• pregnancy

• patient's refusal

• minor or adult under legal protection

• psychiatric ongoing disease

• addiction to opiates

• ongoing opiate treatment

• inability to use a PCA device

• respiratory insuffiency (Vital capacity or maximal expired volume per sec. < 50% of the expected value, or mean PAP > 50 mmHg)

• intra-aortic balloon

• severe renal insuffiency

• history of allergy or intolerance to: morphine, acetaminophen, bupivacaine.